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Since the first recognition of Newcastle disease (ND) in Nigeria, it has been observed to be 
enzootic despite the intensive vaccination policy, leading to significant economic losses in the 
poultry industry. This study evaluated the ability of inactivated oil-emulsion ND Komarov 
vaccine to protect laying chickens from challenge with a velogenic ND virus (VNDV). Two 
hundred and forty pullets were randomly divided into two groups of 120 each viz: vaccinated 
and unvaccinated groups. The vaccinated group was given ND vaccines. At peak production, 32-
weeks of age, vaccinated and unvaccinated laying chickens were sub-divided into four groups of 
sixty birds each designated; Vaccinated and challenged (VAC); Vaccinated and unchallenged 
(VAU); Unvaccinated and challenged (UNC); and Unvaccinated and unchallenged (UNU). 
Groups VAC and UNC were each inoculated intramuscularly with 0.2ml of a VNDV with a 
median embryo infective dose (EID50) of 10
6.46
 per ml. Groups VAU and UNU were each 
inoculated with 0.2ml of phosphate buffered saline. Group VAC showed no clinical signs, no 
clear lesions grossly and mild histopathologic changes. Group UNC showed severe depression, 
anorexia, whitish-greenish diarrhoea, nervous signs and necrosis of the organs. All infected 
groups (VAC and UNC) showed significantly higher (P < 0.05) sero-conversion determined by 
enzyme-linked immunosorbent assay (ELISA) 10 days post-challenge.  The inactivated oil-
emulsion ND Komarov vaccine not only induced higher immunity, but also conferred long-
lasting protection against morbidity, mortality, and severe organ damage in VAC group. This 
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Newcastle disease (ND) is a highly 
contagious viral disease of poultry that 
causes significant economic losses to the 
poultry industry worldwide since 1926 
(Alexander, 2001). The causative agent, ND 
virus (NDV), is an avian paramyxovirus 
serotype 1 group, classified in the genus 
Avulavirus, subfamily Paramyxovirinae, 
family Paramyxoviridae, order 
Mononegavirales (Mayo, 2002; Lamb et al., 
2005). Strains of NDV can be classified into 
three pathotypes (lentogenic, mesogenic and 
velogenic) on the basis of the severity of 
disease they cause in chickens (Miller and 
Koch, 2013). Strains are defined as virulent 
if they (1) have three or more basic amino 
acids at position 113–116 of the un-cleaved 
fusion protein cleavage site (F0) with a 
phenylalanine at position 117, or (2) obtain a 
intracerebral pathogenicity index (ICPI) 
value of ≥ 0.7 in day-old chickens (Gallus 
gallus) (Alexander and Senne, 2008; OIE, 
2012). Because of the severe economic 
consequences of an outbreak of velogenic 
NDV (VNDV) in commercial poultry, ND 
belongs on the List of Notifiable Diseases to 
the World Organisation for Animal Health 
(OIE), (OIE, 2013). Infection with VNDV 
produces severe diarrhoea, extensive 
haemorrhage and ulceration in the digestive 
tract, necrosis in the spleen and lymphoid 
tissues, and high morbidity and mortality in 
infected susceptible flocks (Okoye et al., 
2000; Sa’idu et al., 2006; Igwe et al., 2014). 
ND is also associated with neurological 
signs and a severe drop in the egg 
productivity of laying hens (Bwala et al., 
2012; Igwe, 2015; Silva et al., 2016). 
Chickens that survive infection with virulent 
Newcastle disease virus develop a long 
lasting immunity to further infection with 
Newcastle disease virus (FAO, 2002). 
Reducing losses of large numbers of laying 
flocks to virulent Newcastle disease is an 
essential first step to improving their 
productivity and decreasing economic losses 
at harvest. Newcastle disease is mostly 
controlled by the use of vaccines in Nigeria 
(Adu et al, 1990). The goal of current 
vaccination procedures is to induce 
protective immunity while producing a 
minimal antagonistic response / immune 
responses without causing severe disease in 
the bird (FAO, 2002). The traditional 
vaccination programme in Nigeria typically 
involves the use of 3 types of live ND 
vaccines, and the regime of four successive 
vaccinations (Hichner B1 at day old 
intraocularly, ND Lasota (orally) at day 21, 
at 6 and 16 weeks ND Komarov 
(intramuscularly) (Adu et al., 1990) 
designed to build sufficient immunity to 
withstand/control the endemic velogeniic 
ND strains.  Although the efficacy of 
currently available NDV vaccines against 
velogenic NDV is widely accepted (Okeke 
and Lamorde, 1988; Kapczynski and King, 
2005), ND outbreaks in Nigeria have been 
frequent and widespread in both vaccinated 
and unvaccinated flocks (Adu et al., 1990; 
Shoyinka, 1983). Furthermore, the 
characterization of NDV strains isolated 
from outbreaks in several regions in Nigeria 
(Solomon et al., 2012; Shittu et al., 2016) 
underscores the need for continued 
evaluation of NDV vaccines and vaccination 
programs to controlling spread of disease. In 
Nigeria farmers have been using 
combinations of live lentogenic vaccines 
and subsequent revaccination with imported 
oil-emulsion inactivated ND-Komarov 
vaccines following different schedules of 
vaccination. These combinations of live and 
inactivated oil-emulsion vaccines are 
assumed to be highly effective against ND 
although there is paucity of information on 
the immune performances of combination of 
these vaccines. The objectives of the present 
study were to extend the knowledge of 
protection by inactivated oil-emulsion NDV 
vaccine, against clinical disease, lesions and 




determine the immune response, following challenge with VNDV in laying chickens.
MATERIALS AND METHODS 
This study was scrutinized and approved by 
the University Committee on Medical and 




Two hundred and forty Isa-Brown pullets 
obtained from Zartech Farms, Nigeria were 
used for the study. They were randomly 
assigned into four groups of 60 each. The 
groupings and their treatments were 
Vaccinated against ND and challenged with 
VNDV group (VAC); Vaccinated against 
ND and unchallenged group (VAU); 
Unvaccinated and challenged with VNDV 
group (UNC); and Unvaccinated and 
unchallenged group (UNU). Brooding of all 
the pullets was done on deep litter. Each of 
the groups was brooded separately under the 
same environmental conditions at the animal 
facilities. Feed and water were provided ad 
libitum. General care of the birds was 
provided in accordance with the Institutional 
Animal Care and Use Committee, as 
outlined in the Guide for the Care and Use 
of Agricultural Animals in Agricultural 
Research and Teaching and Quarantine 
Service. 
 
Velogenic NDV Inoculum 
The virus used was the VNDV strain, 
duck/Nigeria/903/KUDU–113/1992 (Shittu 
et al., 2016). The virus was isolated in Kuru, 
Plateau State of Nigeria from an apparently 
healthy duck and characterized biologically
 
by Echeonwu et al. (1993). The inoculum 
had a median embryo infective dose (EID50) 
of 10
6.46
 per ml. 
 
Experimental Design 
The experiment was designed to determine 
if current industry routine NDV vaccine 
strategies would protect against the 
challenge of VNDV to 32 weeks old laying 
chickens at the peak of egg production (that 
is, to extend the knowledge of protection by 
live, and inactivated oil-emulsion NDV 
vaccines, against clinical disease and 
lesions). Also to determine the immune 
response in laying chickens following 
challenged with VNDV. 
 
Experiment I 
Comparison of protective immunity to 
VNDV before and following challenge of 
vaccinated and unvaccinated laying 
chickens: Pullets in groups VAC and VAU 
were given ND vaccines intraocularly at day 
old- Hitchner B1, four weeks ND Lasota 
vaccine orally in drinking water, and at nine 
and sixteen weeks of age, Komarov, an oil-
emulsion inactivated vaccine, 
intramuscularly (IM) according to National 
Veterinary Research Institute (NVRI), Vom, 
Nigeria and Biovac®, Israel respectively. 
Each bird in group VAC and VAU was 
inoculated intramuscularly (IM) with 0.2 ml 
of the inoculum at the beginning of the 
experiment (day 0). Unchallenged birds 
were each inoculated intramuscularly with 
0.2 ml of phosphate buffered saline (PBS) 
(groups VAU & UNU) as placebo. The birds 
were observed twice daily for clinical signs 
of ND from day 0 through to day 21 PC. 
Three birds in each group were humanely 
euthanized and along with the mortalities 
examined for pathological changes on days 
3, 5, 6, 7, 8, 10, 15 and 21 PC. In the 
challenged groups the euthanized birds were 
those showing clinical signs. The ovary, 
infundibulum, magnum, isthmus, uterus and 
vagina were carefully excised and fixed in 
Bouin’s fluid for 12 hours and thereafter 
transferred to 70% alcohol.  The samples of 
the spleen were fixed in 10% formalin for 
not less than 24 hours. The fixed tissues 
were trimmed, and processed to paraffin 
using routine procedures.  Five µm sections 
were cut and used for haematoxylin and 
eosin (H&E) staining. 





Serological/Immune response in vaccinated 
and unvaccinated laying chickens before 
and following challenged with VNDV: At 
32weeks-of age, each bird in groups VAC 
and UNC was challenged by inoculating 
intramuscularly (IM) with 0.2 ml of the 
inoculum at the beginning of the experiment 
(day 0). Birds in group VAU and UNU were 
each inoculated intramuscularly with 0.2 ml 
of phosphate buffered saline (PBS) as 
placebo and kept as unchallenged controls.  
Blood samples were collected from ten (10) 
birds in each group on days 0, 10, 15 and 21 
post challenge (PC). The separated serum 
was stored at -20ºC until used for NDV 
enzyme-linked immunosorbent assay 
(ELISA) test. A commercial ELISA test kit 
(Flockcheck
TM
 IDEXX Laboratories 
Inc.,Westbrook,ME) was used to test serum 
for antibodies against NDV. Chicken serum 
samples were diluted 1:500 and incubated in 
96-well microtiter plates containing NDV 
antigen. The ELISA was performed 
according to the manufacturers’ 
recommendations. Duplicate titres were 
obtained and calculated using XCHEK 
software (IDEXX Laboratories Inc) at 
Virology Department, NVRI, Vom, Plateau 
State Nigeria. An optical density of 650 nm 
wavelength was used to detect the colour 
change using an Emax reader (Molecular 
Devices, Sunnyvale, CA). 
Statistical Analysis 
Data generated from immune responses 
were subjected to one way analysis of 
variance (ANOVA). Variant means were 
separated post hoc using the least significant 
difference (LSD) method (Okafor 1992). 
Probabilities less or each to 0.05 were 







Protection of vaccinated commercial laying 
chickens against challenge, compared with 
unvaccinated infected group: No clinical 
signs of Newcastle disease were observed in 
any laying chicken prior to challenge. 
Protection from VNDV challenge was 
determined by absence of clinical signs 
during the 21days PC observation period 
and protection from severe damage in the 
organs (Table 1). Laying chickens in the 
vaccinated challenged group had no clinical 
signs throughout the course of the study. 
Eighty two percent of the unvaccinated 
challenged group displayed severe 
depression, ruffled feathers, reduction in 
feed and water consumption at day 2 to 3 
PC. At day 4 PC, morbidity was 100%, and 
all laying chickens in this group displayed 
whitish-greenish diarrhoea which soiled the 
vent. Mortality was first observed on day 5 
PC. Peak mortality occurred on day 6 PC 
and involved 21 laying chickens. Some of 
the remaining laying chickens showed by 
days 6 to 9 PC, nervous signs such as head 
tremors, torticollis, paralysis of the legs and 
wings were evident in 6 hens by days 6 to 9 
PC. Total mortality was 89.58% excluding 
the euthanized sacrificed layers (Table 1). 
In the VAC laying chickens the muscles of 
the breast, thigh and legs were mildly 
congested at days 6 to 10 PC. At days 6 to 
10 PC the caecal tonsils were mildly 
ulcerated, haemorrhagic and contained 
cheesy necrotic materials. The female 
reproductive tract showed no clear lesions 
grossly (Figures 1 and 2), however, there 
were mild histopathologic changes (Figure 
3) throughout the experimental period. In 
the UNC laying chickens, gross lesions were 
congested breast, thigh and leg muscles by 
days 5 to 10 PC, petechiae haemorrhages at 
the tips of the proventricular glands and 
haemorrhagic band at oesophageal-
proventricular junction at days 5 to 7 PC. 
Caecal tonsils showed severe swollen, 




TABLE 1: Protection of vaccinated commercial laying chickens with inactivated oil-emulsion vaccines against challenge with virulent 




titer at day 0 
 Protection 
   Days post challenge 
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0 0 0 0 0 0 
UNU 0 ± 0.00
b 
(n=10) 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 
A= Number positive for clinical signs. 
B= Total number of layers per group. It is also the number of layers remaining in a group when first and subsequent mortalities were 
observed 







Plate 1: The oviduct of group VAC laying 
chickens compared with group VAU on day 3 
PI showed no lesion 
 Plate 2: No appreciable change of the ovarian 
follicles in group VAC laying chickens 




Plate 3. Section of infundibulum of a 
sacrificed laying chicken from group VAC, 
showing hyperaemia (double arrow), 
inflammatory cells (arrows) in submucosa and 
lamina propria on day 6 PI. H & E, X200 
 Plate 4: Swollen and congested oviduct with 
hyperaemic ovarian follicles (arrows) in 
sacrificed group UNC compared with group 
UNU laying chickens on day 3 PI 
 
ulcerated and haemorrhagic lesions by day 5 
PC which persisted to day 21 PC in less severe 
form. Spleens were enlarged and mottled 3 to 
6 days PC. At days 3 to 6 PC the kidneys were 
swollen, congested or haemorrhagic. 
The reproductive tract showed marked 
swelling, hyperaemia and haemorrhages in the 
ovarian follicles and all through the oviduct at 
day 3 PC (Figure 4). The infundibulum at day 
3 PC had extensive areas of oedema, 
heterophil accumulation and scattered 
lymphocytes which expanded the mucosal 
folds and submucosa. There were multifocal 
large scattered lymphocytic aggregates
VAC 




in the submucosa. There was deciliation of 
superficial epithelial lining. At days 5 to 6 PC, 
there was generalized extensive, marked 
necrosis of the epithelial cells and ulceration 
(Figures 5a and b). The cells of the lymphoid 
follicles were also necrotic. Similar 
histopathologic changes were observed in the 
magnum and isthmus. In the uterus (shell 
gland) the most common change was acute 
inflammation of the uterus at day 3 PC. The 
oedema led to swelling of the organ with 
separation of the necrotic tubular glands and 
multifocal accumulations of inflammatory 
cells (Figure 6). By days 5 and 6 PC there was 
generalized and extensive oedema, severe 
necrosis of the superficial mucosal epithelium 
and tubular glands, ulceration of luminal 
epithelia with exocytosis and scattering of 
necrotic debris and inflammatory cells and 
macrophages in the lumen (Figure 7). More 
inflammatory cells were present in the 
submucosa. 
The spleen of VAC chickens was 
histologically normal whereas the spleen of 
laying chickens in the UNC group had severe 
necrosis of the lymphocytes around the 
sheathed arteriole (Figures 8 and 9). 
Regeneration of the lost lymphocytes was 
observed by day 10 PC. Neither clinical signs 
of disease, severe lesions nor mortality were 
observed in the non-challenged control groups 
during the course of the experiment. 
 
Experiment 2 
Serological response of laying chickens, 
compared with uninfected groups before and 
following challenge with VNDV: No clinical 
signs of Newcastle disease were observed in 
any vaccinated laying chicken prior to 
challenge. Protection from VNDV challenge 
was determined by absence of clinical signs 
during the 21-days PC observation period. 
Birds in the unchallenged control group had 
no clinical signs during the course of the 
study. All pre-challenge sera at 32 weeks-of 
age (day 0) tested positive to NDV with 
significantly high (P < 0.05) antibody titers of 
between 1473 and 1484 in VAC and VAU 
groups (Table 2). After challenge, the NDV 





Plate 5a: The reproductive tract of dead UNC 
laying chickens on day 6 PI. The oviduct is thin-
walled and flaacid, atrophic with pale (in 
middle), haemorrhagic, congested and atretic 
ovarian follicles, compared with the control 
group, UNU on the right 
 Plate 5b: Section of infundibulum: Severe 
oedema (asteriks), necrosis and ulceration in 
mucosa and submucosa (double arrow), 
necrosis and depletion (red arrow) in the sub-
mucosal lymphoid follicle of a dead UNC 
laying chicken on day 6 PI. H & E, X400 







Plate 6: Section of uterus of a sacrificed UNC 
laying chicken showing severe oedema 
separating the necrotic shell glands (double 
arrows) on day 3 PI. Note non/de-ciliation of 
mucosa epithelium (arrows). H & E, X400 
 Plate 7: Section of uterus of a dead UNC 
laying chicken showing severe oedema 
(asterisks) and necrosis of shell glands (double 
arrows), and ulceration of mucosa epithelia 




Plate 8: Section of spleen of a dead UNC laying 
chicken, showing severe necrosis and depletion 
of lymphoid follicles around the sheathed 
arterioles (arrow) on day 6 PI. H & E, X400 
 Plate 9: Section of spleen of a sacrificed VAC 
laying chicken showing lymphoid follicles 
around the sheathed arterioles (arrow) on day 6 
PI. H & E, X400 
 
was still positive and significantly (p < 0.05) 
high by day 10 and 15 PC (1158.4 and 
1010.5), and rose gradually by day 21 PC. In 
the VAU group, the NDV antibody titer 
fluctuated but still remained positive from 
days 10 to 21 PC (707.5).  Prior to VNDV 
challenge, the NDV antibody titer was 
negative in UNC and UNU groups. On 10, 15 
and 21 days PC the NDV antibody titers 
increased significantly (P < 0.05) in surviving 
UNC groups (Table 2). The non-vaccinated 
non-challenged laying chickens did not 
contain detectable antibody titers to NDV 
throughout the course of the study (Table 2).




Table 2: Serum antibody responses pre and post challenge with virulent NDV (Kudu 113) in 
commercial laying chickens vaccinated with live ND-Hitcher B1 and ND Lasota, and inactivated oil 
emulsion Komarov vaccines, at 9 and 16 weeks-of-age, compared with the unvaccinated group 
 ELISA antibody titer  (log10)  
 Days post challenge 
Groups  00 10 15 21 































UNC 0 ± 0.00
b   











UNU 0 ± 0.00
b 
(n=10) 0 ± 0.00
b
 (n=10) 0 ± 0.00
b




 Different superscripts in a column indicate significant differences 




The continued outbreaks of velogenic NDV in 
domestic poultry in Nigeria emphasize the 
importance for continued research on vaccine 
efficacy against newly isolated strains. 
Information regarding vaccine efficacy against 
VNDV strains will provide valuable 
knowledge for the poultry industry when 
considering vaccine types and vaccination 
strategies. The present study demonstrated 
that priming with live ND B1and ND Lasota 
vaccines and subsequent re-vaccination with 
inactivated oil-emulsion vaccines at 9 and 16 
weeks of age induced high immunity levels 
that resulted in increased and persistent 
antibody titres at point of challenge at 32 
weeks (16 weeks after the last vaccination), 
and 21 days PC. This finding is in agreement 
with Eidson et al. (1982) who reported that 
laying chickens vaccinated with live ND 
vaccines and subsequently re-vaccinated with 
an inactivated oil emulsion ND vaccine had 
higher and more persistent antibody titres than 
birds vaccinated with live ND vaccines. This 
increased immune response might be due to 
the higher number (quantity) of virus titres 
and primary antigenic stimulation and is in 
agreement with the observation by Rue et al. 
(2011), that a pronounced and rapid innate 
immune response may be induced by virulent 
NDV. 
Moreover, vaccination with live Newcastle 
disease (ND) vaccines and subsequent 
revaccination with an inactivated oil emulsion 
ND vaccine protected laying chickens against 
morbidity and mortality from challenge with 
the highly virulent Kudu-113 VNDV. All 
vaccinated birds displayed antibody titres 
against at the day of challenge and protection 
from disease post challenge. The protective 
role of antibody against NDV has been 
described (Reynolds and Maraqa, 2000). The 
results extend the findings of prior reports of 
protection in poultry against velogenic NDV 
using commercial live and inactivated oil-
emulsion vaccines (Eidson et al., 1982; 
Liljebjelke et al., 2008). 
Having established the longer and persistent 
protection (immunity) with priming with live 
vaccines and then inactivated oil-emulsion 
vaccines, the effect on protection against 
clinical disease, death and severe damage to 
the organs following challenge was examined. 
A positive correlation was observed between 
presence of antibody titres at day of challenge 
and protection from disease 21 day PC in the 
vaccinated and challenged group. In addition, 
it showed that the commercial industry




vaccination programs with inactivated oil-
emulsion vaccines are effective at protecting 
commercial laying chickens from VNDV 
challenge. A positive correlation was also 
observed between the presence of antibody 
titres at challenge and protection from disease.  
These birds had no clinical signs of ND, no 
clear lesions grossly and there were mild 
histopathologic changes. This is in agreement 
with the study by Eidson et al. (1982) stating 
that breeder flocks revaccinated with live 
LaSota ND vaccine had lower egg production 
than the flocks vaccinated with inactivated 
vaccine. Similarly, Dai et al. (2008) reported 
that priming with live lentogenic vaccines, 
followed by boosting with inactivated oil-
emulsion vaccines weeks later, induced a 
reasonable antibody response and provided 
long-lasting protection against a virulent NDV 
field strain.  
However, these vaccines provided chickens 
with full protection from disease caused by 
VNDV, as no mortality or disease symptoms 
were observed in any of the vaccinated 
challenged chickens. Alexander (2011) 
reported that the clinical signs of virulent 
NDVs in vaccinated chickens were greatly 
diminished in relationship to the antibody 
level achieved (Allan et al., 1978). The 
vaccines were also protective against severe 
damage in the organs viz, spleen, caecal 
tonsils and reproductive tract as these birds 
were resistant to challenge and had mild 
histopathologic changes. This is in agreement 
with the report of studies by Jeon et al. (2008) 
and Kapczynski and King (2005) on the 
protective efficacy of NDV vaccines. Also, 
the main lesions in the organs of the 
unvaccinated infected group were marked 
swelling, hyperaemia, haemorrhages, necrosis 
in the reproductive tract, lymphoid follicles 
and spleen observed in this study are in 
agreement with severe lesions observed in 
birds after experimental and natural infections 
with VVNDV (Brown et al., 1999; Okoye et 
al., 2000; Igwe et al., 2014). 
 
CONCLUSION 
NDV is an economically important and 
frequently isolated worldwide viral pathogen 
whose listed status with OIE marks its 
importance to both commercial poultry 
producers and poultry trading countries. 
Control of VNDV through use of vaccines is 
regularly and routinely practiced by all major 
poultry companies to provide immunological 
protection against disease. The results of this 
study demonstrated the importance of the 
protective role of priming with live Newcastle 
disease (ND) vaccines and subsequent re-
vaccination with an inactivated oil emulsion 
ND vaccine in laying chickens. This longer 
protective effect will offset the additional cost 
of the oil emulsion ND vaccine as well as the 
cost of administering each individual bird 
every 90 days with a live ND Lasota vaccine. 
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